Background The increasing multidrug resistance among gram-negative uropathogens
necessitates new treatments for serious infections. Plazomicin is an aminoglycoside with …

Increasing antimicrobial resistance among uropathogens limits treatment options for patients
with complicated urinary tract infection (cUTI). Plazomicin, a new aminoglycoside, has in …

OBJECTIVE: Preterm birth is classified by the presence of uterine contractions and/or
amniorrhexis at clinical presentation. This classification does not include prior cervical change. We …

Background Convenient administration of coronavirus disease 2019 (COVID-19) treatment
in community settings is desirable. Sotrovimab is a pan-sarbecovirus dual-action monoclonal …

… Deborah Cebrik … Plotnik D , Sager J E , Aryal M , Fanget M C , Peter A , Schmid M A ,
Cebrik D , Mogalian E , Boundy K , Yeh W W , Griffin P , Reyes M . A phase 1 study in healthy …

Background: Influenza A results in significant morbidity and mortality. VIR-2482, an engineered
human monoclonal antibody with extended half-life, targets a highly conserved epitope …

Background: The ability to administer coronavirus disease 2019 (COVID-19) treatment
easily in community settings is desirable. Sotrovimab, a pan-sarbecovirus neutralising …

Background Preterm birth remains a major cause of neonatal morbidity and mortality worldwide.
Short cervical length (CL) as measured by transvaginal ultrasound (TVU) in the second …

Objective Prophylactic 17-hydroxyprogesterone caproate (17P) reduces risk of preterm birth
(PTB) in singleton pregnancies with maternal history of prior PTB but does not reduce PTB …

Methods: Patients were identified based on meeting≥ 1 criteria: hematologic malignancy or
solid malignancy requiring treatment, transplant recipient, rheumatologic/inflammatory …